Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: a French nationwide multicenter cohort study - ANRS0001s COV-POPART - l'unam - université nantes angers le mans Accéder directement au contenu
Article Dans Une Revue International Journal of Infectious Diseases Année : 2024

Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: a French nationwide multicenter cohort study - ANRS0001s COV-POPART

1 F-CRIN, Innovative clinical research network in vaccinology (I-REIVAC)
2 VBIC - Virulence Bactérienne et Infections Chroniques
3 CHU Nîmes - Centre Hospitalier Universitaire de Nîmes
4 VRI - Vaccine Research Institute [Créteil, France]
5 Hôpital Henri Mondor
6 UB - Université de Bordeaux
7 UMS 54 MART - Methods and Applied Research for Trial [UNIV Bordeaux]
8 CHU ST-E - Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne]
9 CIRI - Centre International de Recherche en Infectiologie
10 HCL - Hospices Civils de Lyon
11 CHU - Hôpital Archet 2 [Nice]
12 UniCA - Université Côte d'Azur
13 CHU Angers - Centre Hospitalier Universitaire d'Angers
14 CIC - Centre d’Investigation Clinique [Tours] CIC 1415
15 AP-HM, Marseille
16 CHU Montpellier
17 CIC Montpellier
18 BPH - Bordeaux population health
19 CHU de Bordeaux - Centre Hospitalier Universitaire de Bordeaux
20 CHUGA - Centre Hospitalier Universitaire [CHU Grenoble]
21 CIC Grenoble - Centre d'Investigation Clinique [Grenoble]
22 Service des Maladies Infectieuses et Tropicales [Brest]
23 iPLESP - Institut Pierre Louis d'Epidémiologie et de Santé Publique
24 CHU Saint-Antoine [AP-HP]
25 Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Ponchaillou]
26 CHU Nantes - Centre Hospitalier Universitaire de Nantes = Nantes University Hospital
27 CHRU Tours - Centre Hospitalier Régional Universitaire de Tours
28 UM - Université de Montpellier
29 CHU Pitié-Salpêtrière [AP-HP]
30 Le Trait d'Union, centre de soins de l'infection par le VIH [CHU Strasbourg]
31 Hôpital Foch [Suresnes]
32 ANRS - MIE - ANRS - Maladies infectieuses émergentes
33 HEGP - Hôpital Européen Georges Pompidou [APHP]
34 UVE - Unité des Virus Emergents
35 SISTM - Statistics In System biology and Translational Medicine

Résumé

BACKGROUND: This study aimed to compare the humoral responses to mRNA COVID-19 vaccination in PWH and HIV-negative individuals. METHODS: We included PWH with an undetectable viral load under ART and HIV-negative participants from the French nationwide ANRS COV-POPART cohort who had received two doses of vaccine as a primary vaccination. We compared humoral response between controls and PWH, stratified by CD4 cell count (< 200/mm(3) and ≥ 200/mm(3) CD4 cell counts) at 1, 6 and 12 months after primary vaccination. RESULTS: A total of 1776 participants were included in this analysis, 684 PWH (99% were on ART, median CD4 counts 673 cells/mm(3)) and 1092 controls. At 1 month, after adjustment on age, sex and BMI, PWH had lower seroneutralization titers than controls and PWH with < 200 CD4 cell/mm3 had lower anti- Spike SARS-CoV-2 IgG antibodies. Same results were found at 6 months. However, in participants who received a booster dose between 6 and 12 months post primary vaccination, we did not observe differences between PWH and controls at 12 months. CONCLUSION: PWH had high responses to primary mRNA COVID-19 vaccination. In those who received a booster dose after six months, the humoral response at 12 months increased to similar levels to controls, even in those with low CD4 counts at baseline.
Fichier principal
Vignette du fichier
BPH_IntJInfectDis_2024_Loubet.pdf (1.92 Mo) Télécharger le fichier
Origine Publication financée par une institution

Dates et versions

hal-04627501 , version 1 (27-06-2024)

Licence

Identifiants

Citer

Paul Loubet, Jean-Daniel Lelievre, Alexis Francois, Elisabeth Botelho-Nevers, Christian Chidiac, et al.. Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: a French nationwide multicenter cohort study - ANRS0001s COV-POPART. International Journal of Infectious Diseases, 2024, 146, pp.107110. ⟨10.1016/j.ijid.2024.107110⟩. ⟨hal-04627501⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More